Information from combined 1H and 31P NMR studies of cell extracts: differences in metabolism between drug-sensitive and drug-resistant MCF-7 human breast cancer cells.

Combined analysis of both 1H and 31P NMR spectra of extracts of drug-sensitive and multidrug-resistant MCF-7 human breast cancer cells enabled quantitative comparisons between the concentrations of major metabolites, as well as of their precursors. In resistant cells high energy phosphorus compounds, phosphocreatine and ATP, and also their precursors, creatine and ADP, were elevated compared to the sensitive cells. In phospholipid metabolism, the sensitive cells showed higher phosphocholine and phosphoethanolamine concentrations than the resistant cells, but choline levels were similar. These results delineated the differences in control of metabolic pathways between drug-sensitive and drug-resistant cells.

[1]  T. Tsuruo,et al.  Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170- to 180-kilodalton membrane glycoprotein is an ATPase. , 1988, The Journal of biological chemistry.

[2]  I. Campbell,et al.  Proton nuclear magnetic resonance of intact Friend leukemia cells: phosphorylcholine increase during differentiation. , 1982, Science.

[3]  A. Long,et al.  A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.

[4]  G. Fronza,et al.  Modulation of glycerophosphorylcholine and glycerophosphorylethanolamine in rice shoots by the environment oxygen level , 1985 .

[5]  J. Cohen,et al.  Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review. , 1989, Cancer research.

[6]  T. Ng,et al.  NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. , 1984, Biochimica et biophysica acta.

[7]  J. Cohen,et al.  Metabolism of peripheral lymphocytes, interleukin‐2‐activated lymphocytes and tumor‐infiltrating lymphocytes from 31 NMR studies , 1989, FEBS letters.

[8]  Steen Rg,et al.  Response of solid tumors to chemotherapy monitored by in vivo 31P nuclear magnetic resonance spectroscopy: a review. , 1989 .

[9]  R. Lyon,et al.  Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. , 1988, Cancer research.

[10]  W. D. Yushok.  Control mechanisms of adenine nucleotide metabolism of ascites tumor cells. , 1971, The Journal of biological chemistry.

[11]  M. Bárány,et al.  Phosphorus-31 nuclear magnetic resonance detection of unexpected phosphodiesters in muscle. , 1976, Biochemistry.

[12]  G. Batist,et al.  Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. , 1986, Cancer research.

[13]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[14]  G. Navon,et al.  Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism. , 1990, Cancer research.